Risk factors for death during pulmonary tuberculosis treatment in Korea: A multicenter retrospective cohort study

Journal of Korean Medical Science

Volumn 29, Issue 9, 2014, Pages 1226-1231

  Kwon, Yong Soo ^a   Kim, Yee Hyung ^b   Song, Jae Uk ^c   Jeon, Kyeongman ^d   Song, Junwhi ^e   Ryu, Yon Ju ^f   Choi, Jae Chol ^g   Kim, Ho Cheol ^h   Koh, Won Jung ^d  

^a Chonnam National University Medical School   (South Korea)

^b Kyung Hee University College of Medicine   (South Korea)

^c School of Medicine   (South Korea)

^d Sungkyunkwan University School of Medicine   (South Korea)

^e Sungkyunkwan University School of Medicine   (South Korea)

^f Ewha Womans University   (South Korea)

^g Chung Ang University College of Medicine   (South Korea)

^h Gyeongsang National University School of Medicine   (South Korea)

Author keywords

Korea; Mortality; Pulmonary; Therapeutics; Tuberculosis

Indexed keywords

TUBERCULOSTATIC AGENT;

ADULT; AGED; ANEMIA; CLINICAL TRIAL; COHORT ANALYSIS; COMPLICATION; DYSPNEA; FEMALE; HEART DISEASE; HUMAN; INTENSIVE CARE UNIT; MALE; MIDDLE AGED; MORTALITY; MULTICENTER STUDY; MULTIVARIATE ANALYSIS; NEOPLASM; PROGNOSIS; RETROSPECTIVE STUDY; RISK FACTOR; SEX DIFFERENCE; SOUTH KOREA; TREATMENT OUTCOME; TUBERCULOSIS;

ADULT; AGED; ANEMIA; ANTITUBERCULAR AGENTS; COHORT STUDIES; DYSPNEA; FEMALE; HEART DISEASES; HUMANS; INTENSIVE CARE UNITS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASMS; PROGNOSIS; REPUBLIC OF KOREA; RETROSPECTIVE STUDIES; RISK FACTORS; SEX FACTORS; TREATMENT OUTCOME; TUBERCULOSIS;

EID: 84929939240     PISSN: 10118934     EISSN: 15986357     Source Type: Journal    
DOI: 10.3346/jkms.2014.29.9.1226     Document Type: Article

References (38)

1. World Health Organization. Global tuberculosis report 2013. Geneva: World Health Organization, 2013. Available at http://www.who.int/tb/publications/global_report/en [accessed on 1 March 2014].
2. Korea Centers for Disease Control and Prevention. Annual report on the notified tuberculosis patients in Korea 2012. Cheongwon: Korea Centers for Disease Control and Prevention, 2013. Available at http://tbfree.cdc.go.kr/tbfree/cmm/BoardList.do?boardType=REPORT&id=4500 [accessed on 1 March 2014].
3. Park YK, Park YS, Na KI, Cho EH, Shin SS, Kim HJ. Increased tuberculosis burden due to demographic transition in Korea from 2001 to 2010. Tuberc Respir Dis (Seoul) 2013; 74: 104-10.
4. Park YS, Hong SJ, Boo YK, Hwang ES, Kim HJ, Cho SH, Na KI, Cho EH, Shin SS. The national status of tuberculosis using nationwide medical records survey of patients with tuberculosis in Korea. Tuberc Respir Dis (Seoul) 2012; 73: 48-55.
5. Kim HJ. Current status of tuberculosis in Korea. Korean J Med 2012; 82: 257-62.
6. Statistics Korea. Annual report of deaths by cause 2012. Daejeon: Statistics Korea, 2013. Available at http://kosis.kr/ups/ups_01List01.jsp?grp_no=1005&pubcode=YD&type=F [accessed on 1 March 2014].
7. Mugusi FM, Mehta S, Villamor E, Urassa W, Saathoff E, Bosch RJ, Fawzi WW. Factors associated with mortality in HIV-infected and uninfected patients with pulmonary tuberculosis. BMC Public Health 2009; 9: 409.
8. Waitt CJ, Squire SB. A systematic review of risk factors for death in adults during and after tuberculosis treatment. Int J Tuberc Lung Dis 2011; 15: 871-85.
9. Baussano I, Pivetta E, Vizzini L, Abbona F, Bugiani M. Predicting tuberculosis treatment outcome in a low-incidence area. Int J Tuberc Lung Dis 2008; 12: 1441-8.
10. Duarte EC, Bierrenbach AL, Barbosa da Silva J Jr, Tauil PL, de Fátima Duarte E. Factors associated with deaths among pulmonary tuberculosis patients: a case-control study with secondary data. J Epidemiol Community Health 2009; 63: 233-8.
11. Kim HJ, Lee CH, Shin S, Lee JH, Kim YW, Chung HS, Han SK, Shim YS, Kim DK. The impact of nutritional deficit on mortality of in-patients with pulmonary tuberculosis. Int J Tuberc Lung Dis 2010; 14: 79-85.
12. Lefebvre N, Falzon D. Risk factors for death among tuberculosis cases: analysis of European surveillance data. Eur Respir J 2008; 31: 1256-60.
13. Low S, Ang LW, Cutter J, James L, Chee CB, Wang YT, Chew SK. Mortality among tuberculosis patients on treatment in Singapore. Int J Tuberc Lung Dis 2009; 13: 328-34.
14. Shen X, Deriemer K, Yuan Z, Shen M, Xia Z, Gui X, Wang L, Mei J. Deaths among tuberculosis cases in Shanghai, China: who is at risk? BMC Infect Dis 2009; 9: 95.
15. Vasankari T, Holmström P, Ollgren J, Liippo K, Kokki M, Ruutu P. Risk factors for poor tuberculosis treatment outcome in Finland: a cohort study. BMC Public Health 2007; 7: 291.
16. Dewan PK, Arguin PM, Kiryanova H, Kondroshova NV, Khorosheva TM, Laserson K, Kluge H, Jakubowiak W, Wells C, Kazionny B. Risk factors for death during tuberculosis treatment in Orel, Russia. Int J Tuberc Lung Dis 2004; 8: 598-602.
17. Shimazaki T, Marte SD, Saludar NR, Dimaano EM, Salva EP, Ariyoshi K, Villarama JB, Suzuki M. Risk factors for death among hospitalised tuberculosis patients in poor urban areas in Manila, the Philippines. Int J Tuberc Lung Dis 2013; 17: 1420-6.
18. Oursler KK, Moore RD, Bishai WR, Harrington SM, Pope DS, Chaisson RE. Survival of patients with pulmonary tuberculosis: clinical and molecular epidemiologic factors. Clin Infect Dis 2002; 34: 752-9.
19. Kourbatova EV, Borodulin BE, Borodulina EA, del Rio C, Blumberg HM, Leonard MK Jr. Risk factors for mortality among adult patients with newly diagnosed tuberculosis in Samara, Russia. Int J Tuberc Lung Dis 2006; 10: 1224-30.
20. Cullinan P, Meredith SK. Deaths in adults with notified pulmonary tuberculosis 1983-5. Thorax 1991; 46: 347-50.
21. Kim CW, Kim SH, Lee SN, Lee SJ, Lee MK, Lee JH, Shin KC, Yong SJ, Lee WY. Risk factors related with mortality in patient with pulmonary tuberculosis. Tuberc Respir Dis (Seoul) 2012; 73: 38-47.
22. Lee CH, Hwang JY, Oh DK, Kee MK, Oh E, An JW, Kim J, Do H, Kim HJ, Kim SS, et al. The burden and characteristics of tuberculosis/human immunodeficiency virus (TB/HIV) in South Korea: a study from a population database and a survey. BMC Infect Dis 2010; 10: 66.
23. Hwang JH, Choe PG, Kim NH, Bang JH, Song KH, Park WB, Kim ES, Park SW, Kim HB, Kim NJ, et al. Incidence and risk factors of tuberculosis in patients with human immunodeficiency virus infection. J Korean Med Sci 2013; 28: 374-7.
24. World Health Organization. Haemoglobin concentrations for the diagnosis of anaemia and assessment of severity. WHO/NMH/NHD/MNM/11.1. Geneva: World Health Organization, 2011. Available at http://www.who.int/vmnis/indicators/haemoglobin.pdf [accessed on 1 May 2014].
25. Seung KJ, Bai GH, Kim SJ, Lew WJ, Park SK, Kim JY. The treatment of tuberculosis in South Korea. Int J Tuberc Lung Dis 2003; 7: 912-9.
26. Joint Committee for the Development of Korean Guidelines for Tuberculosis Korea Centers for Disease Control and Prevention. Korean Guidelines for Tuberculosis, 2011. Available at http://tbfree.cdc.go.kr/tbfree/guide.do?page=11&id=4110 [accessed on 1 March 2014].
27. Kim HJ, Bai GH, Kang MK, Kim SJ, Lee JK, Cho SI, Lew WJ. A public-private collaboration model for treatment intervention to improve outcomes in patients with tuberculosis in the private sector. Tuberc Respir Dis 2009; 66: 349-57.
28. World Health Organization. Treatment of tuberculosis: guidelines for national programmes (4th Ed.) WHO/HTM/TB/2009.420. Geneva: World Health Organization, 2009. Available at http://www.who.int/tb/publications/tb_treatmentguidelines/en [accessed on 1 March 2014].
29. Kim YH, Suh GY, Chung MP, Kim H, Kwon OJ, Lim SY, Lim SY, Koh WJ. Treatment of isoniazid-resistant pulmonary tuberculosis. BMC Infect Dis 2008; 8: 6.
30. Kwon YS, Kim YH, Suh GY, Chung MP, Kim H, Kwon OJ, Choi YS, Kim K, Kim J, Shim YM, et al. Treatment outcomes for HIV-uninfected patients with multidrug-resistant and extensively drug-resistant tuberculosis. Clin Infect Dis 2008; 47: 496-502.
31. Kwon YS, Chi SY, Oh IJ, Kim KS, Kim YI, Lim SC, Kim YC. Clinical characteristics and treatment outcomes of tuberculosis in the elderly: a case control study. BMC Infect Dis 2013; 13: 121.
32. Pérez-Guzmán C, Vargas MH, Torres-Cruz A, Villarreal-Velarde H. Does aging modify pulmonary tuberculosis? a meta-analytical review. Chest 1999; 116: 961-7.
33. Jeon DS, Shin DO, Park SK, Seo JE, Seo HS, Cho YS, Lee JY, Kim DY, Kong SJ, Kim YS, et al. Treatment outcome and mortality among patients with multidrug-resistant tuberculosis in tuberculosis hospitals of the public sector. J Korean Med Sci 2011; 26: 33-41.
34. Antoine D, French CE, Jones J, Watson JM. Tuberculosis treatment outcome monitoring in England, Wales and Northern Ireland for cases reported in 2001. J Epidemiol Community Health 2007; 61: 302-7.
35. Balasubramanian R, Garg R, Santha T, Gopi PG, Subramani R, Chandrasekaran V, Thomas A, Rajeswari R, Anandakrishnan S, Perumal M, et al. Gender disparities in tuberculosis: report from a rural DOTS programme in south India. Int J Tuberc Lung Dis 2004; 8: 323-32.
36. Moore RD. Human immunodeficiency virus infection, anemia, and survival. Clin Infect Dis 1999; 29: 44-9.
37. Ryu YJ, Koh WJ, Kang EH, Suh GY, Chung MP, Kim H, Kwon OJ. Prognostic factors in pulmonary tuberculosis requiring mechanical ventilation for acute respiratory failure. Respirology 2007; 12: 406-11.
38. Sharma SK, Mohan A, Banga A, Saha PK, Guntupalli KK. Predictors of development and outcome in patients with acute respiratory distress syndrome due to tuberculosis. Int J Tuberc Lung Dis 2006; 10: 429-35.